<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7232622\results\search\testTrace\results.xml">
  <result pre="four regions (Central, East, Southern and West Africa), with 240" exact="treatment" post="and care sites, six data centres at African, European"/>
  <result pre="date The data include socio-demographic characteristics, clinical outcomes, opportunistic events," exact="treatment" post="regimens, clinic visits and laboratory measurements. They have been"/>
  <result pre="cohort collaboration that collects HIV/AIDS data from HIV care and" exact="treatment" post="programmes, including in sub-Saharan Africa. The regional IeDEA data"/>
  <result pre="regions of IeDEA received data from 240 HIV care and" exact="treatment" post="facilities in 19 sub-Saharan African countries (figure 1A). Close"/>
  <result pre="â€ƒMissing 3 0 0 0 3 (1) Viral load â€ƒRoutine" exact="testing" post="12 16 46 74 148 (62) â€ƒTests performed onsite"/>
  <result pre="offsite 6 13 53 127 199 (83) CD4 monitoring â€ƒRoutine" exact="testing" post="14 6 9 97 126 (53) â€ƒTests performed onsite"/>
  <result pre="11 35 71 120 (50) HIV-1 genotypic drug resistance â€ƒRoutine" exact="testing" post="2 2 10 48 62 (26) Routine tracing of"/>
  <result pre="resistance â€ƒRoutine testing 2 2 10 48 62 (26) Routine" exact="tracing" post="of patients lost to follow-up â€ƒYes 13 19 56"/>
  <result pre="under treatment, which includes sociodemographic characteristics, clinical outcomes, opportunistic events," exact="treatment" post="regimens, clinic visits and laboratory measurements. More recently, the"/>
  <result pre="compared the characteristics and comprehensiveness of adult HIV care and" exact="treatment" post="programmes in sub-Saharan Africa with programmes in the Americas"/>
  <result pre="mental health and substance use disorders,8 or the diagnostic and" exact="screening" post="practices for (drug resistant) tuberculosis in adult and paediatric"/>
  <result pre="in the Treat All era, it also recommends that CD4" exact="testing" post="be replaced by viral load measurement for monitoring of"/>
  <result pre="testing be replaced by viral load measurement for monitoring of" exact="treatment" post="and identification of treatment failure.16Figure 2 shows that in"/>
  <result pre="viral load measurement for monitoring of treatment and identification of" exact="treatment" post="failure.16Figure 2 shows that in Southern and West Africa,"/>
  <result pre="At present, 53% of the active facilities reported routine CD4" exact="testing" post="and 62% routine viral load testing (table 1). The"/>
  <result pre="facilities reported routine CD4 testing and 62% routine viral load" exact="testing" post="(table 1). The US Presidentâ€™s Emergency Plan for AIDS"/>
  <result pre="(3TC) (or emtricitabine (FTC)) and efavirenz (EFV) is the current" exact="treatment" post="of choice. The phasing out of stavudine (D4T) and"/>
  <result pre="to the clinic have increased in recent years. At present," exact="tracing" post="of PLWHIV on ART who were lost to follow-up"/>
  <result pre="had died.46 Coinfections and comorbidities IeDEA investigators have examined the" exact="prevalence" post="and impact of coinfection with hepatitis B and C,"/>
  <result pre="South Africa, Peru and Thailand). Molecular or phenotypic drug susceptibility" exact="testing" post="was done locally and at a reference laboratory. The"/>
  <result pre="reference laboratory. The results showed that inaccurate local drug susceptibility" exact="testing" post="led to undertreatment of drug-resistant tuberculosis and increased mortality.54"/>
  <result pre="used regression discontinuity analysis to examine changes in rapid HIV" exact="treatment" post="initiation after national â€˜Treat Allâ€™ policy adoption in six"/>
  <result pre="project involving all four African regions studies the cascade of" exact="screening" post="for cervical cancer, while the establishment of the South"/>
  <result pre="2collab: UNAIDSUnaids data, 2018 Available: https://www.aidsdatahub.org/unaids-data-2018-unaids-2018 3collab: UNAIDS90-90-90: an ambitious" exact="treatment" post="target to help end the AIDS epidemic. Geneva, Switzerland,"/>
  <result pre="LindegrenML, et al.Characteristics and comprehensiveness of adult HIV care and" exact="treatment" post="programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results"/>
  <result pre="management of mental health and substance use disorders in HIV" exact="treatment" post="settings in low- and middle-income countries within the global"/>
  <result pre="in pediatric antiretroviral therapy programs in low- and middle-income countries:" exact="diagnosis" post="and screening practices. J Pediatric Infect Dis Soc2015;4:30â€&quot;8. 10.1093/jpids/piu02026407355"/>
  <result pre="antiretroviral therapy programs in low- and middle-income countries: diagnosis and" exact="screening" post="practices. J Pediatric Infect Dis Soc2015;4:30â€&quot;8. 10.1093/jpids/piu02026407355 12HornerM-J, ChasimphaS,"/>
  <result pre="10.1186/s13027-019-0228-731073325 14BoulleA, SchomakerM, MayMT, et al.Mortality in patients with HIV-1" exact="infection" post="starting antiretroviral therapy in South Africa, Europe, or North"/>
  <result pre="Retrovirology2013;10:22. 10.1186/1742-4690-10-2223432922 20ZashR, HolmesL, DisekoM, et al.Neural-Tube defects and antiretroviral" exact="treatment" post="regimens in Botswana. N Engl J Med2019;381:NEJMoa1905230:827â€&quot;40. 10.1056/NEJMoa1905230 21ZaniewskiE,"/>
  <result pre="10.1097/QAD.000000000000130628301337 24DaviesM-A, MayM, Bolton-MooreC, et al.Prognosis of children with HIV-1" exact="infection" post="starting antiretroviral therapy in southern Africa. Pediatr Infect Dis"/>
  <result pre="AbrahamAG, et al.Sex-based differences in antiretroviral therapy initiation, switching and" exact="treatment" post="interruptions: global overview from the International epidemiologic databases to"/>
  <result pre="et al.Monitoring and switching of first-line antiretroviral therapy in adult" exact="treatment" post="cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV2015;2:e271â€&quot;8. 10.1016/S2352-3018(15)00087-926423252"/>
  <result pre="39BrinkhofMWG, Pujades-RodriguezM, EggerMMortality of patients lost to follow-up in antiretroviral" exact="treatment" post="programmes in resource-limited settings: systematic review and meta-analysis. PLoS"/>
  <result pre="LyamuyaRE, et al.Estimation of mortality among HIV-infected people on antiretroviral" exact="treatment" post="in East Africa: a sampling based approach in an"/>
  <result pre="mortality for loss to follow-up: a nomogram applied to antiretroviral" exact="treatment" post="programmes in sub-Saharan Africa. PLoS Med2011;8:e1000390. 10.1371/journal.pmed.100039021267057 45YiannoutsosCT, JohnsonLF,"/>
  <result pre="JohnsonLF, BoulleA, et al.Estimated mortality of adult HIV-infected patients starting" exact="treatment" post="with combination antiretroviral therapy. Sex Transm Infect2012;88 Suppl 2:i33â€&quot;43."/>
  <result pre="on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV" exact="treatment" post="programmes. J Int AIDS Soc2018;21:e25084. 10.1002/jia2.25084 47HectorJ, VinikoorM, ChilengiR,"/>
  <result pre="47HectorJ, VinikoorM, ChilengiR, et al.No impact of hepatitis B virus" exact="infection" post="on early mortality among human immunodeficiency virus-infected patients in"/>
  <result pre="48WandelerG, MulengaL, HobbinsM, et al.Absence of active hepatitis C virus" exact="infection" post="in human immunodeficiency virus clinics in Zambia and Mozambique."/>
  <result pre="51BrownSA, AbbasS, DaviesM-A, et al.Brief report: pediatric cancer burden and" exact="treatment" post="resources within the pediatric IeDEA Consortium. J Acquir Immune"/>
  <result pre="sarcoma. Cancer Med2016;5:914â€&quot;28. 10.1002/cam4.61826823008 53CarlucciJG, Blevins PeratikosM, KippAM, et al.Tuberculosis" exact="treatment" post="outcomes among HIV/TB-Coinfected children in the International epidemiology databases"/>
  <result pre="Immune Defic Syndr2017;75:156â€&quot;63. 10.1097/QAI.000000000000133528234689 54ZÃ¼rcherK, BallifM, FennerL, et al.Drug susceptibility" exact="testing" post="and mortality in patients treated for tuberculosis in high-burden"/>
  <result pre="Epidemiol2017;46:797. 10.1093/ije/dyw21127864413 60TymejczykO, BrazierE, YiannoutsosCT, et al.Changes in rapid HIV" exact="treatment" post="initiation after national &quot;treat all&quot; policy adoption in 6"/>
  <result pre="HetrickA, JaquetA, et al.Substance use and universal access to HIV" exact="testing" post="and treatment in sub-Saharan Africa: implications and research priorities."/>
  <result pre="et al.Substance use and universal access to HIV testing and" exact="treatment" post="in sub-Saharan Africa: implications and research priorities. J Virus"/>
  <result pre="combination antiretroviral therapy in an era of changing criteria for" exact="treatment" post="initiation. J Int AIDS Soc2018;21:e25200. 10.1002/jia2.2520030614622 68collab: Anderegg N,"/>
  <result pre="count at the start of antiretroviral therapy: collaborative study of" exact="treatment" post="programs. Clin Infect Dis2018;66:893â€&quot;903. 10.1093/cid/cix91529373672 69collab: Collaborative Initiative for"/>
 </snippets>
</snippetsTree>
